ACTRN12620000615987已完成未知
A multicentre, open label, active control, randomised controlled trial to determine the comparative effectiveness of a customised mobile phone text messaging intervention for women post-gestational diabetes, supported by data from activity monitors, compared to activity monitors alone, for improving the diabetes risk factors of weight, physical activity, and diet.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 177
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Educational / counselling / training
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- Female
入选标准
- •1) have GDM diagnosed on the basis of local glucose tolerance test (GTT) criteria
- •2) own a smart phone with internet access
- •3) age >18 years
- •4) have adequate English literacy to read text messages
排除标准
- •1) already using an activity monitor
- •2) has pre-existing diabetes
- •3) has a GTT result in the diabetes mellitus in pregnancy” range in the first 20 weeks of pregnancy (fasting glucose >=7.0 mmol/L or 2 hour glucose >=11.1 mmol/L)
- •4) on medications which affect glucose metabolism
- •5) twin pregnancy
- •6) significant fetal disorder likely to require increased care in first 6 months post-partum (eg major malformation, major inheritable disorder)
- •7) planning to spend >1 month overseas within 6 months post-partum
- •8) unable to walk regularly due to physical limitations
研究者
相似试验
进行中(未招募)
1 期
Rivaroxaban for treatment in venous thrombosis in childreVenous ThrombosisEUCTR2014-000565-47-FRBayer HealthCare AG500
进行中(未招募)
1 期
Rivaroxaban for treatment in venous thrombosis in childreVenous ThrombosisEUCTR2014-000565-47-ITBayer HealthCare AG500
进行中(未招募)
1 期
Rivaroxaban for treatment in venous thrombosis in childreVenous ThrombosisEUCTR2014-000565-47-SKBayer AG500
进行中(未招募)
1 期
Rivaroxaban for treatment in venous thrombosis in childreMedDRA version: 20.0 Level: LLT Classification code 10066899 Term: Venous thromboembolism System Organ Class: 100000004866Venous ThrombosisEUCTR2014-000565-47-ATBayer AG500
进行中(未招募)
1 期
Rivaroxaban for treatment in venous thrombosis in childreVenous ThrombosisEUCTR2014-000565-47-FIBayer AG500
